Judes Poirier /newsroom/taxonomy/term/1982/all en Experts: FDA approves much-debated Alzheimer's drug panned by experts /newsroom/channels/news/experts-fda-approves-much-debated-alzheimers-drug-panned-experts-331414 <p>U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer's patients. (<a href="https://www.ctvnews.ca/health/fda-approves-much-debated-alzheimer-s-drug-panned-by-experts-1.5459470" target="_blank">CTV News</a>)</p> Tue, 08 Jun 2021 20:48:35 +0000 frederique.mazerolle@mcgill.ca 269362 at /newsroom Judes Poirier /newsroom/judes-poirier Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 22898 at /newsroom